The successful development of vaccines for triple negative breast cancer (TNBC) has been hindered because there are no identified tumor-associated antigens. As an alternative to peptide vaccines, the administration of tumor lysates has been investigated in TNBC to activate the immune system against tumors, wherein a mixture of tumor-specific lysates...